About Exagen Inc.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact:
ir@exagen.com
760.560.1525
Source:
2024 GlobeNewswire, Inc., source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.912 USD | +16.59% | +40.59% | -3.92% |
03:34pm | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
About Exagen Inc.
For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).
Contact:
ir@exagen.com
760.560.1525
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-3.92% | 28.46M | |
+18.31% | 83.07B | |
-29.42% | 70.89B | |
+3.59% | 28.32B | |
-7.25% | 17.73B | |
+2.07% | 17.43B | |
+0.75% | 15.64B | |
+6.95% | 13.46B | |
+8.40% | 12.82B | |
+68.53% | 12.69B |